Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of AgeDisorders of Excessive Somnolence, Dyssomnias, Excessive Daytime Sleepiness, Sleep Disorders, Intrinsic, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 12025-12-24NCT07082829

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Centessa Pharmaceuticals (UK) Limited5

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site #1LincolnUnited States1
Site #2EatontownUnited States1
Site #3New YorkUnited States1